Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

Trial Profile

Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

Recruiting
Phase of Trial: Phase III

Latest Information Update: 16 May 2018

At a glance

  • Drugs Travoprost (Primary)
  • Indications Glaucoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Apr 2018 Status changed from planning to recruiting.
    • 19 Sep 2017 New trial record
    • 14 Sep 2017 According to a Glaukos Corporation media release, the company expects to initiate this trial in early 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top